Efficacy and Safety of Ivabradine Once-Daily Prolonged-Release versus Twice-Daily Immediate-Release Formulation in Patients with Stable Chronic Heart Failure with Systolic Dysfunction: A Randomized, Double-Blind, Phase 3 Non-Inferiority (PROFICIENT) Study

被引：0
|
作者：
Ajit Mullasari
机构：
[1] Madras Medical Mission,
来源：
Cardiology and Therapy | 2020年 / 9卷
关键词：
Heart failure; Heart rate; Immediate-release; Ivabradine; Once-daily; Prolonged-release systolic dysfunction;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：505 / 521
页数：16
相关论文
共 49 条
  • [21] Once-weekly trelagliptin versus daily alogliptin in Japanese patients with type 2 diabetes: a randomised, double-blind, phase 3, non-inferiority study
    Inagaki, Nobuya
    Onouchi, Hitoshi
    Maezawa, Hideaki
    Kuroda, Shingo
    Kaku, Kohei
    LANCET DIABETES & ENDOCRINOLOGY, 2015, 3 (03): : 191 - 197
  • [22] A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Efficacy and Safety of TAK-438 (20 mg Once-Daily) Compared to Lansoprazole (30 mg Once-Daily) in Patients With Erosive Esophagitis
    Iwakiri, Katsuhiko
    Umegaki, Eiji
    Hiramatsu, Naoki
    Sakurai, Yuuichi
    Hori, Tetsuharu
    Kudou, Kentarou
    Nishimura, Akira
    Ashida, Kiyoshi
    GASTROENTEROLOGY, 2014, 146 (05) : S741 - S741
  • [23] Phase II/III, randomized, double-blind, parallel-group study of monthly delayed-release versus daily immediate-release risedronate tablets in Japanese patients with involutional osteoporosis
    Soen, Satoshi
    Kishimoto, Hideaki
    Hagino, Hiroshi
    Sone, Teruki
    Ohishi, Hiroaki
    Fujimoto, Tsukasa
    Sasaki, Emma
    Tanaka, Sakae
    Sugimoto, Toshitsugu
    JOURNAL OF BONE AND MINERAL METABOLISM, 2020, 38 (01) : 86 - 98
  • [24] Phase II/III, randomized, double-blind, parallel-group study of monthly delayed-release versus daily immediate-release risedronate tablets in Japanese patients with involutional osteoporosis
    Satoshi Soen
    Hideaki Kishimoto
    Hiroshi Hagino
    Teruki Sone
    Hiroaki Ohishi
    Tsukasa Fujimoto
    Emma Sasaki
    Sakae Tanaka
    Toshitsugu Sugimoto
    Journal of Bone and Mineral Metabolism, 2020, 38 : 86 - 98
  • [25] Efficacy and safety of twice-daily tramadol hydrochloride bilayer sustained-release tablets with an immediate release component for postherpetic neuralgia: Results of a Phase III, randomized, double-blind, placebo-controlled, treatment-withdrawal study
    Kawai, Shinichi
    Hasegawa, Jun
    Ito, Hideki
    Fukuuchi, Yasuo
    Nakano, Hideshi
    Ohtani, Hideaki
    Sasaki, Kazutaka
    Adachi, Takeshi
    PAIN PRACTICE, 2023, 23 (03) : 277 - 289
  • [26] A PHASE 3, RANDOMIZED, DOUBLE-BLIND, MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF VONOPRAZAN (20 MG ONCE DAILY) COMPARED TO LANSOPRAZOLE (30 MG ONCE-DAILY) IN PATIENTS WITH EROSIVE ESOPHAGITIS (EE)
    Chen, Minhu
    Chun, Hoon Jai
    Sheu, Bor-Shyang
    Chong, Chui Fung
    Funao, Nobuo
    Zhou, Wen
    Goh, Khean Lee
    GASTROENTEROLOGY, 2018, 154 (06) : S237 - S237
  • [27] A MULTICENTER, DOUBLE-BLIND, RANDOMIZED STUDY TO COMPARE THE SAFETY AND EFFICACY OF ONCE-DAILY ORG-10172 AND TWICE-DAILY LOW-DOSE HEPARIN IN PREVENTING DEEP-VEIN THROMBOSIS IN PATIENTS WITH ACUTE ISCHEMIC STROKE
    DUMAS, R
    WOITINAS, F
    KUTNOWSKI, M
    NIKOLIC, I
    BERBERICH, R
    ABEDINPOUR, F
    ZOECKLER, S
    GREGOIRE, F
    JERKOVIC, M
    EGBERTS, JFM
    STIEKEMA, JCJ
    AGE AND AGEING, 1994, 23 (06) : 512 - 516
  • [28] Efficacy, Safety and Pharmacokinetics of Once-Daily, MeltDose® Tacrolimus (Envarsus® XR) Versus Twice-Daily Tacrolimus (Prograf®) in De Novo Kidney Transplant Recipient Sub-Groups: A 2 Year Phase 3 Randomized, Double-Blind, Double-Dummy, Trial
    Bunnapradist, S.
    Denny, J.
    Waybill, M.
    West-Thielke, P.
    Steinberg, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
  • [29] Once-daily mometasone plus indacaterol versus mometasone or twice-daily fluticasone plus salmeterol in patients with inadequately controlled asthma (PALLADIUM): a randomised, double-blind, triple-dummy, controlled phase 3 study
    van Zyl-Smit, Richard N.
    Kruell, Matthias
    Gessner, Christian
    Gun, Yasuhiro
    Noga, Oliver
    Richard, Alexia
    de los Reyes, Amy
    Shu, Xu
    Pethe, Abhijit
    Tanase, Ana-Maria
    D'Andrea, Peter
    LANCET RESPIRATORY MEDICINE, 2020, 8 (10): : 987 - 999
  • [30] Efficacy, safety, and tolerability of lacosamide monotherapy versus controlled-release carbamazepine in patients with newly diagnosed epilepsy: a phase 3, randomised, double-blind, non-inferiority trial
    Baulac, Michel
    Rosenow, Felix
    Toledo, Manuel
    Terada, Kiyohito
    Li, Ting
    De Backer, Marc
    Werhahn, Konrad
    Brock, Melissa
    LANCET NEUROLOGY, 2017, 16 (01): : 43 - 54
12345